论文部分内容阅读
本月全球药品研发进展取得成效的药物有52个,较上月减少了3个,其中进入注册阶段的药物数量较上月显著减少,进入注册前阶段和Ⅲ期临床研究阶段的药品数量均有所增加。进入注册阶段的有24个,较上月大幅减少了11个。其中6个为全球首次注册的新活性物质和新制剂,其余
In the month, the number of drugs that made progress in drug research and development globally was 52, down 3 from the previous month. The number of drugs entering the registration phase decreased significantly from the previous month. The number of drugs entering the pre-registration phase and the phase III clinical research phase Increase. There were 24 registrations, a substantial decrease of 11 from the previous month. Six of them were the first new active substances and new preparations registered in the world, the rest